• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»radiology AI

Can Hologic’s breast imaging AI close one of mammography’s most stubborn detection gaps?

By Pallavi Madhiraju on April 21, 2026   Medical Devices & Diagnostics  

Can Hologic’s breast imaging AI close one of mammography’s most stubborn detection gaps?

Hologic’s latest breast imaging AI data suggests stronger detection of hard-to-find cancers. Read what it could mean for screening adoption.

What FDA clearance means for Median Technologies eyonis LCS in a crowded AI radiology market

By Pallavi Madhiraju on March 3, 2026   Medical Devices & Diagnostics  

What FDA clearance means for Median Technologies eyonis LCS in a crowded AI radiology market

Median Technologies advances eyonis LCS after FDA clearance. Discover what this means for AI lung cancer screening and European expansion.

Aidoc secures FDA clearance for first AI triage system covering 14 acute conditions in CT

By Pallavi Madhiraju on January 25, 2026   Medical Devices & Diagnostics  

Aidoc secures FDA clearance for first AI triage system covering 14 acute conditions in CT

Aidoc’s CARE AI gets FDA clearance for 14-condition CT triage. Find out how it may reshape emergency imaging, hospital workflows, and clinical AI governance.

Can embedded AI help Philips challenge GE and Siemens in imaging software?

By Pallavi Madhiraju on December 1, 2025   Medical Devices & Diagnostics  

Can embedded AI help Philips challenge GE and Siemens in imaging software?

Philips unveils AVW 16 and new AI integrations at RSNA 2025. Find out how its cloud-native platform strategy could reshape diagnostic imaging workflows.

Recent Posts

  • Can Servier’s $2.65bn Edgewise deal reshape the muscular dystrophy drug race?
  • Can Convergent Therapeutics define the next prostate cancer standard after Lu-PSMA therapy?
  • Why T-CURX’s Pantherna acquisition could matter for the future of cell therapy manufacturing
  • Is Amgen’s bispecific lung cancer drug becoming a global standard after chemotherapy failure?
  • Fulgent Genetics’ oncology pivot gets sharper as FID-007 shows Phase 2 activity at ASCO 2026
  • Minghui and Qilu push MHB088C forward as prostate cancer ADC race tightens
  • Why Aphranel’s EU MDR approval could sharpen competition in CaHA dermal fillers
  • Oricell’s ASCO 2026 liver cancer data put GPC3 CAR-T back in the spotlight
  • Can Lilly turn Hanmi’s sonefpeglutide into the next long-acting GLP-2 rare disease bet?
  • Can enicepatide and petrelintide help Genentech build a differentiated obesity franchise?
  • Can Summit and Akeso turn ivonescimab into a global lung cancer challenger?
  • Why Tempus AI’s Lens upgrade matters for precision oncology drug development
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes